The role of the glutathione system in seizures induced by diphenyl diselenide in rat pups

The present study investigated the role of the glutathione system in seizures induced by diphenyl diselenide (PhSe)(2) (50 mg/kg) in rat pups (post natal day, 12-14). Reduced glutathione (GSH) (300 nmol/site; i.c.v.), administered 20 min before (PhSe)(2), abolished the appearance of seizures, protected against the inhibition of catalase and delta-aminolevulinic dehydratase (delta-ALA-D) activities and increased glutathione peroxidase (GPx) activity induced by (PhSe)(2). Administration of L-buthionine sulfoximine (BSO, a GSH-depleting compound) (3.2 mu mol/site; i.c.v.) 24 h before (PhSe)(2) increased the percentage (42-100%) of rat pups which had seizure episodes, reduced the onset for the first convulsive episode. In addition, BSO increased thiobarbituric acid reactive species (TBARS) levels and decreased GSH content, catalase, delta-ALA-D and Na+ K+-ATPase activities. Treatment with sub effective doses of GSH (10 nmol/site) and D-2-amino-7-phosphonoheptanoic acid (AP-7, an antagonist of the glutamate site at the NMDA receptor; 5 mg/kg, i.p.) abolished the appearance of seizures induced by (PhSe)(2) in rat pups. Sub effective doses of GSH and kynurenic acid (an antagonist of strychnine-insensitive glycine site at the NMDA receptor; 40 mg/kg, i.p.) were also able in abolishing the appearance of seizures induced by (PhSe)2. In conclusion, administration of GSH protected against seizure episodes induced by (PhSe)2 in rat pups by reducing oxidative stress and, at least in part, by acting as an antagonist of glutamate and glycine modulatory sites in the NMDA receptor. (C) 2011 Published by Elsevier Ireland Ltd.